CRSP News and Press, CRISPR Therapeutics AG

2026-03-11 07:07:24 ET More on CRISPR Therapeutics Is A Vertex Buyout Of Crispr Therapeutics Inevitable? Here's My Take Crispr Therapeutics: Very High Risk, But Even Higher Potential Reward CRISPR Therapeutics AG (CRSP) Presents at Citi's 2026 Virtual Oncology Leader...

ZUG, Switzerland and BOSTON, March 11, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics AG (Nasdaq: CRSP) (the “Company”) today announced the pricing of $550 million aggregate principal amount of its convertible senior notes due 2031 (the “notes”) in a private offering (th...

2026-03-11 06:00:21 ET More on CRISPR Therapeutics Is A Vertex Buyout Of Crispr Therapeutics Inevitable? Here's My Take Crispr Therapeutics: Very High Risk, But Even Higher Potential Reward CRISPR Therapeutics AG (CRSP) Presents at Citi's 2026 Virtual Oncology Leader...

2026-03-10 15:43:00 ET Just a few dollars away from rekindling a budding recovery effort, shares of biotechnology outfit CRISPR Therapeutics (NASDAQ: CRSP) were instead upended today. As of 3:21 p.m. ET Tuesday this stock is down just over 12% on news that the organization is not on...

2026-03-10 07:07:56 ET More on CRISPR Therapeutics Is A Vertex Buyout Of Crispr Therapeutics Inevitable? Here's My Take Crispr Therapeutics: Very High Risk, But Even Higher Potential Reward CRISPR Therapeutics AG (CRSP) Presents at Citi's 2026 Virtual Oncology Leader...

ZUG, Switzerland and BOSTON, March 10, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics AG (Nasdaq: CRSP) (the “Company”) today announced its intention to offer, subject to market conditions and other factors, $350 million aggregate principal amount of its convertible senior notes due 2...

2026-03-09 16:07:53 ET Investment Overview I have been covering CRISPR Therapeutics AG ( CRSP ), the Zug, Switzerland-based gene therapy developer that leverages the Nobel Prize-winning CRISPR /Cas9 gene editing biotechnology pioneered by Dr. Emmanuelle Charpentier, a sc...

2026-03-04 13:43:00 ET Gene editing, a set of techniques used to alter sections of an organism's DNA, is helping scientists cure diseases previously considered untreatable. That's why biotechs that specialize in gene editing and that succeed in making important breakthroughs could make ...

2026-03-04 09:35:44 ET Health Care ETFs: ( XLV ), ( VHT ), ( IHI ), ( IXJ ), ( IYH ), ( FHLC ), ( XPH ), ( PPH ...

2026-03-02 12:20:00 ET CRISPR Therapeutics (NASDAQ: CRSP) is a company that can potentially help revolutionize healthcare. Its gene-editing therapies can be game changers for patients living with illnesses and conditions that might otherwise be difficult to treat. The company al...